Search Results - "Beaton, D"

Refine Results
  1. 1

    Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial by Joy, Tisha R, McKenzie, Charles A, Tirona, Rommel G, Summers, Kelly, Seney, Shannon, Chakrabarti, Subrata, Malhotra, Neel, Beaton, Melanie D

    Published in World journal of gastroenterology : WJG (07-01-2017)
    “…AIM To evaluate the effect of sitagliptin vs placebo on histologic and non-histologic parameters of nonalcoholic steatohepatitis(NASH).METHODS Twelve patients…”
    Get full text
    Journal Article
  2. 2

    The contributions of the endocannabinoid system and stress on the neural processing of reward stimuli by Filbey, F.M., Beaton, D., Prashad, S.

    “…The brain's endocannabinoid system plays a crucial role in reward processes by mediating appetitive learning and encoding the reinforcing properties of…”
    Get full text
    Journal Article
  3. 3

    CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease by Woolsey, Sarah J, Mansell, Sara E, Kim, Richard B, Tirona, Rommel G, Beaton, Melanie D

    Published in Drug metabolism and disposition (01-10-2015)
    “…Nonalcoholic fatty liver disease (NAFLD) is the leading cause of liver disease in the Western world, given its association with obesity, type 2 diabetes, and…”
    Get full text
    Journal Article
  4. 4

    Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis by Beaton, Melanie D

    Published in Canadian journal of gastroenterology (01-06-2012)
    “…Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review by ELLIOT-GIBSON, V, BOGOCH, E. R, JAMAL, S. A, BEATON, D. E

    Published in Osteoporosis international (01-10-2004)
    “…Fragility fractures are a strong indicator of underlying osteoporosis (OP). With the risk of future fracture being increased 1.5- to 9.5-fold following a…”
    Get full text
    Journal Article
  7. 7

    A taxonomy for responsiveness by Beaton, D.E, Bombardier, C, Katz, J.N, Wright, J.G

    Published in Journal of clinical epidemiology (01-12-2001)
    “…Responsiveness is quickly becoming a critical criterion for the selection of outcomes measures in studies of treatment effectiveness, economic appraisals, and…”
    Get full text
    Journal Article
  8. 8

    Coordinator-based systems for secondary prevention in fragility fracture patients by Marsh, D., Åkesson, K., Beaton, D. E., Bogoch, E. R., Boonen, S., Brandi, M.-L., McLellan, A. R., Mitchell, P. J., Sale, J. E. M., Wahl, D. A.

    Published in Osteoporosis international (01-07-2011)
    “…The underlying causes of incident fractures—bone fragility and the tendency to fall—remain under-diagnosed and under-treated. This care gap in secondary…”
    Get full text
    Journal Article
  9. 9

    Lab-on-Chip Measurement of Nitrate and Nitrite for In Situ Analysis of Natural Waters by Beaton, Alexander D, Cardwell, Christopher L, Thomas, Rupert S, Sieben, Vincent J, Legiret, François-Eric, Waugh, Edward M, Statham, Peter J, Mowlem, Matthew C, Morgan, Hywel

    Published in Environmental science & technology (04-09-2012)
    “…Microfluidic technology permits the miniaturization of chemical analytical methods that are traditionally undertaken using benchtop equipment in the laboratory…”
    Get full text
    Journal Article
  10. 10

    Nitrate and Nitrite Variability at the Seafloor of an Oxygen Minimum Zone Revealed by a Novel Microfluidic In-Situ Chemical Sensor by Yücel, Mustafa, Beaton, Alexander D, Dengler, Marcus, Mowlem, Matthew C, Sohl, Frank, Sommer, Stefan

    Published in PloS one (10-07-2015)
    “…Microfluidics, or lab-on-a-chip (LOC) is a promising technology that allows the development of miniaturized chemical sensors. In contrast to the surging…”
    Get full text
    Journal Article
  11. 11

    Phase II clinical trial of phlebotomy for non‐alcoholic fatty liver disease by Beaton, M. D., Chakrabarti, S., Levstik, M., Speechley, M., Marotta, P., Adams, P.

    Published in Alimentary pharmacology & therapeutics (01-04-2013)
    “…Summary Background Elevated iron indices are described in non‐alcoholic fatty liver disease and iron reduction has been suggested as a potential therapy. Aim…”
    Get full text
    Journal Article
  12. 12

    Cost-effectiveness of a fracture liaison service—a real-world evaluation after 6 years of service provision by Yong, J. H. E., Masucci, L., Hoch, J. S., Sujic, R., Beaton, D.

    Published in Osteoporosis international (01-01-2016)
    “…Summary The cost-effectiveness of a less intensive fracture liaison service is unknown. We evaluated a fracture liaison service that had been educating and…”
    Get full text
    Journal Article
  13. 13

    Five-year refracture rates of a province-wide fracture liaison service by Sujic, R., Beaton, D.E., Mamdani, M., Cadarette, S.M., Luo, J., Jaglal, S., Sale, J.E.M., Jain, R., Bogoch, E.

    Published in Osteoporosis international (01-08-2019)
    “…Summary We examined the 5-year refracture rate of 6543 patients and found an overall rate of 9.7%. Adjusted analysis showed that presenting with multiple…”
    Get full text
    Journal Article
  14. 14

    Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients by Sale, J. E. M., Beaton, D., Posen, J., Elliot-Gibson, V., Bogoch, E.

    Published in Osteoporosis international (01-07-2011)
    “…This study aims to determine osteoporosis (OP) investigation and treatment within post-fracture initiatives conducted in fracture clinics and other orthopedic…”
    Get full text
    Journal Article
  15. 15

    GaAs1-xBix light emitting diodes by LEWIS, R. B, BEATON, D. A, XIANFENG. LU, TIEDJE, T

    Published in Journal of crystal growth (15-03-2009)
    “…GaAs1-xBix light emitting diodes have been grown and characterized. The p-i-n structure uses a intrinsic layer with a central GaAs1-xBix light emitting layer…”
    Get full text
    Conference Proceeding Journal Article
  16. 16

    Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis by Queiroga, F., Cembalo, S.M., Epstein, J., Maxwell, L., Buttel, T., Copenhaver, C., Cross, M., Hunter, D., King, L., Callahan, L., March, L., Beaton, D.E., Guillemin, F.

    Published in Seminars in arthritis and rheumatism (01-04-2024)
    “…To evaluate the domain match (truth) and feasibility of candidate instruments assessing flare in knee and hip osteoarthritis (OA) according to the identified…”
    Get full text
    Journal Article
  17. 17

    Kinetically limited growth of GaAsBi by molecular-beam epitaxy by Ptak, A.J., France, R., Beaton, D.A., Alberi, K., Simon, J., Mascarenhas, A., Jiang, C.-S.

    Published in Journal of crystal growth (2012)
    “…The growth of GaAsBi alloys is plagued by the appearance of Bi droplets due to excess Bi that accumulates during growth. Here we present an alternate growth…”
    Get full text
    Journal Article
  18. 18

    Multiple simultaneous fractures are associated with higher all-cause mortality: results from a province-wide fracture liaison service by Sujic, R., Luo, J., Beaton, D.E., Bogoch, E.R., Sale, J.E.M., Jaglal, S., Jain, R., Mamdani, M.

    Published in Osteoporosis international (01-02-2020)
    “…Summary Mortality rates in our fracture liaison service ranged from 2.7% at year 1 to 14.8% at year 5 post-screening. Presentation with multiple simultaneous…”
    Get full text
    Journal Article
  19. 19

    Lab-on-chip analyser for the in situ determination of dissolved manganese in seawater by Geißler, Felix, Achterberg, Eric P., Beaton, Alexander D., Hopwood, Mark J., Esposito, Mario, Mowlem, Matt C., Connelly, Douglas P., Wallace, Douglas

    Published in Scientific reports (27-01-2021)
    “…A spectrophotometric approach for quantification of dissolved manganese (DMn) with 1-(2-pyridylazo)-2-naphthol (PAN) has been adapted for in situ application…”
    Get full text
    Journal Article
  20. 20

    Measuring change in psychosocial working conditions: methodological issues to consider when data are collected at baseline and one follow-up time point by Smith, P, Beaton, D

    “…If policy makers and employers are to take health issues into account when making decisions that will impact on work practices and work environments, they will…”
    Get full text
    Journal Article